Cannulate faster with Secretin ERCP
ChiRhoStim® assists in cannulation and identification of the ampulla of Vater or minor papilla, especially when patients have either pancreatic divisum or scar tissue. (See images below)
Using ChiRhoStim® will shorten cannulation time by 32% and achieve successful cannulation in 67% of cases compared with 8% who did not receive Secretin.
ChiRhoStim® (Human Secretin) Indication
FACILITATION OF THE IDENTIFICATION OF THE AMPULLA OF VATER AND ACCESSORY PAPILLA DURING ERCP:
Administration of ChiRhoStim® may be given when difficulty is encountered by the endoscopist in identifying the ampulla of Vater for reasons including anatomic deformity secondary to prior surgery, radiation therapy, peptic ulcer disease, tumors, etc. or in identifying the accessory papilla in patients with pancreas divisum. A test dose of ChiRhoStim® 0.2 mcg (0.1 mL) is injected intravenously to test for possible allergic reactions. A dose of 0.2 mcg/kg of body weight intravenously over 1 minute will result in visible excretion of pancreatic fluid from the orifices of these papilla enabling their identification and facilitating cannulation.